Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.

Virus research - 1 Mar 2008

Donalisio Manuela, Cornaglia Maura, Landolfo Santo, Lembo David

Abstract excerpt

Host immune response to human papillomavirus (HPV) is a crucial factor in viral clearance and control of persistent infections. The existence of an intercellular control mechanism mediated by cytokines to suppress HPV-gene transcription and to prevent malignant conversion of HPV-infected cells, h...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular Senescence
Share to Gene Expression Regulation, Viral
Share to Human papillomavirus 16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-4

Share to Oncogene Proteins, Viral

Share to Papillomavirus E7 Proteins

Share to Transforming Growth Factor beta1

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 18206261
DOI: 10.1016/j.virusres.2007.12.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18206261-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.PMID 18206261Read ↗

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIFSemantic proximity Read ↗

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.Semantic proximity Read ↗

High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene ExpressionSemantic proximity Read ↗

Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical KeratinocytesSemantic proximity Read ↗

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene TranscriptionSemantic proximity Read ↗

E6/E7 and E6* From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in KeratinocytesSemantic proximity Read ↗

E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.Semantic proximity Read ↗

Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.Semantic proximity Read ↗

Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer CellsSemantic proximity Read ↗

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cellsSemantic proximity Read ↗

Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.Semantic proximity Read ↗

The effects of interferon on the expression of human papillomavirus oncogenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.